Skip Navigation


European Heart Journal Advance Access originally published online on January 17, 2008
European Heart Journal 2008 29(4):557-563; doi:10.1093/eurheartj/ehm607
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/4/557    most recent
ehm607v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Marcassa, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcassa, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement

Claudio Marcassa1,*, Jeroen J. Bax2, Frank Bengel3, Birger Hesse4, Claus L. Petersen5, Eliana Reyes6, Richard Underwood on behalf of the European Council of Nuclear Cardiology (ECNC), the European Society of Cardiology Working Group 5 (Nuclear Cardiology and Cardiac CT), and the European Association of Nuclear Medicine Cardiovascular Committee6

1 Cardiology Department, S. Maugeri Foundation, IRCCS, Scientific Institute of Veruno, V. Revislate 13, 28010 Veruno, NO, Italy
2 Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
3 Division of Nuclear Medicine, John Hopkins University School of Medicine, Baltimore, MD, USA
4 Department of Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
5 Department of Nuclear Medicine, Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark
6 National Heart and Lung Institute, Imperial College London, London, UK

Received 15 August 2007; revised 15 November 2007; accepted 6 December 2007; online publish-ahead-of-print 17 January 2008.

* Corresponding author. Tel: +39 0322884711, Fax: +39 0322884269, Email: claudio.marcassa{at}fsm.it

See page 531 for the editorial comment on this article (doi:10.1093/eurheartj/ehm544)

Mortality rates due to coronary artery disease (CAD) have declined in recent years as result of improved prevention, diagnosis, and management. Nonetheless, CAD remains the leading cause of death worldwide with most casualties expected to occur in developing nations. Myocardial perfusion scintigraphy (MPS) provides a highly cost-effective tool for the early detection of obstructive CAD in symptomatic individuals and contributes substantially to stratification of patients according to their risk of cardiac death or nonfatal myocardial infarction. MPS also provides valuable information that assists clinical decision-making with regard to medical treatment and intervention. A large body of evidence supports the current applications of MPS, which has become integral to several guidelines for clinical practice.

Key Words: Coronary artery disease • Cost-effectiveness • Myocardial perfusion scintigraphy • Radionuclide • Scintigraphy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Cardiac computed tomography: indications, applications, limitations, and training requirements: Report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology
Stephen Schroeder, Stephan Achenbach, Frank Bengel, Christof Burgstahler, Filippo Cademartiri, Pim de Feyter, Richard George, Philipp Kaufmann, Andreas F. Kopp, Juhani Knuuti, Dieter Ropers, Joanne Schuijf, Laurens F. Tops, and Jeroen J. Bax
EHJ 2008 29: 531-556. [Abstract] [Full Text]  





Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.